Literature DB >> 28856150

Hypertension and left ventricular hypertrophy.

Wilbert S Aronow1.   

Abstract

Entities:  

Year:  2017        PMID： 28856150      PMCID： PMC5555990          DOI： 10.21037/atm.2017.06.14

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  25 in total

Review 1.  The progression of hypertensive heart disease.

Authors:  Mark H Drazner
Journal:  Circulation       Date:  2011-01-25       Impact factor: 29.690

2.  Usefulness of echocardiographic left ventricular hypertrophy in predicting new coronary events and atherothrombotic brain infarction in patients over 62 years of age.

Authors:  W S Aronow; M Koenigsberg; K S Schwartz
Journal:  Am J Cardiol       Date:  1988-05-01       Impact factor: 2.778

3.  Association of heart failure hospitalizations with combined electrocardiography and echocardiography criteria for left ventricular hypertrophy.

Authors:  Eva Gerdts; Peter M Okin; Kurt Boman; Kristian Wachtell; Markku S Nieminen; Björn Dahlöf; Richard B Devereux
Journal:  Am J Hypertens       Date:  2012-03-29       Impact factor: 2.689

4.  Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study.

Authors:  D Levy; R J Garrison; D D Savage; W B Kannel; W P Castelli
Journal:  N Engl J Med       Date:  1990-05-31       Impact factor: 91.245

5.  Effects of captopril and minoxidil on left ventricular hypertrophy in resistant hypertensive patients: a 6 month double-blind comparison.

Authors:  J Julien; M A Dufloux; R Prasquier; G Chatellier; D Menard; P F Plouin; J Menard; P Corvol
Journal:  J Am Coll Cardiol       Date:  1990-07       Impact factor: 24.094

6.  Usefulness of Left Ventricular Mass and Geometry for Determining 10-Year Prediction of Cardiovascular Disease in Adults Aged >65 Years (from the Cardiovascular Health Study).

Authors:  Chintan S Desai; Traci M Bartz; John S Gottdiener; Donald M Lloyd-Jones; Julius M Gardin
Journal:  Am J Cardiol       Date:  2016-06-14       Impact factor: 2.778

7.  Congestive heart failure, coronary events and atherothrombotic brain infarction in elderly blacks and whites with systemic hypertension and with and without echocardiographic and electrocardiographic evidence of left ventricular hypertrophy.

Authors:  W S Aronow; C Ahn; I Kronzon; M Koenigsberg
Journal:  Am J Cardiol       Date:  1991-02-01       Impact factor: 2.778

8.  Left ventricular mass and incidence of coronary heart disease in an elderly cohort. The Framingham Heart Study.

Authors:  D Levy; R J Garrison; D D Savage; W B Kannel; W P Castelli
Journal:  Ann Intern Med       Date:  1989-01-15       Impact factor: 25.391

9.  Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events.

Authors:  Peter M Okin; Richard B Devereux; Sverker Jern; Sverre E Kjeldsen; Stevo Julius; Markku S Nieminen; Steven Snapinn; Katherine E Harris; Peter Aurup; Jonathan M Edelman; Hans Wedel; Lars H Lindholm; Björn Dahlöf
Journal:  JAMA       Date:  2004-11-17       Impact factor: 56.272

10.  Left Ventricular Hypertrophy Regression During Antihypertensive Treatment in an Outpatient Clinic (the Campania Salute Network).

Authors:  Mai Tone Lønnebakken; Raffaele Izzo; Costantino Mancusi; Eva Gerdts; Maria Angela Losi; Grazia Canciello; Giuseppe Giugliano; Nicola De Luca; Bruno Trimarco; Giovanni de Simone
Journal:  J Am Heart Assoc       Date:  2017-03-08       Impact factor: 5.501
View more
  14 in total

Review 1.  The Influence of Dietary Salt Beyond Blood Pressure.

Authors:  Austin T Robinson; David G Edwards; William B Farquhar
Journal:  Curr Hypertens Rep       Date:  2019-04-25       Impact factor: 5.369

2.  Hypertension, aortic stenosis, and aortic regurgitation.

Authors:  Wilbert S Aronow
Journal:  Ann Transl Med       Date:  2018-02

3.  miR-145-5p targets paxillin to attenuate angiotensin II-induced pathological cardiac hypertrophy via downregulation of Rac 1, pJNK, p-c-Jun, NFATc3, ANP and by Sirt-1 upregulation.

Authors:  Yu-Lan Yeh; Kuan-Ho Lin; V Bharath Kumar; Tamilselvi Shanmugam; Marthandam Asokan Shibu; Ray-Jade Chen; Chia-Hua Kuo; Tsung-Jung Ho; V Vijaya Padma; Chih-Yang Huang
Journal:  Mol Cell Biochem       Date:  2021-04-22       Impact factor: 3.396

4.  The prognostic implications of ST-segment and T-wave abnormalities in patients undergoing regadenoson stress SPECT myocardial perfusion imaging.

Authors:  Muhammad Shahzeb Khan; Abdul Wahab Arif; Rami Doukky
Journal:  J Nucl Cardiol       Date:  2020-10-08       Impact factor: 5.952

5.  Regression from pathological hypertrophy in mice is sexually dimorphic and stimulus specific.

Authors:  Deanna L Muehleman; Claudia Crocini; Alison R Swearingen; Christopher D Ozeroff; Leslie A Leinwand
Journal:  Am J Physiol Heart Circ Physiol       Date:  2022-03-18       Impact factor: 4.733

Review 6.  Pharmacotherapy for hypertension-induced left ventricular hypertrophy.

Authors:  Leire Leache; Marta Gutiérrez-Valencia; Rosa M Finizola; Elizabeth Infante; Bartolome Finizola; Jordi Pardo Pardo; Yris Flores; Ricardo Granero; Kaduo J Arai
Journal:  Cochrane Database Syst Rev       Date:  2021-10-10

7.  A randomized controlled trial of metformin on left ventricular hypertrophy in patients with coronary artery disease without diabetes: the MET-REMODEL trial.

Authors:  Mohapradeep Mohan; Shaween Al-Talabany; Angela McKinnie; Ify R Mordi; Jagdeep S S Singh; Stephen J Gandy; Fatima Baig; Muhammad S Hussain; U Bhalraam; Faisel Khan; Anna-Maria Choy; Shona Matthew; John Graeme Houston; Allan D Struthers; Jacob George; Chim C Lang
Journal:  Eur Heart J       Date:  2019-11-01       Impact factor: 35.855

8.  Echocardiographic Changes in Newly Diagnosed Type 2 Diabetes Mellitus Patients with and without Hypertension.

Authors:  Zhen Zhao; Can Hou; Xinhua Ye; Jinluo Cheng
Journal:  Med Sci Monit       Date:  2020-01-26

9.  Ryanodine Receptor Type 2: A Molecular Target for Dichlorodiphenyltrichloroethane- and Dichlorodiphenyldichloroethylene-Mediated Cardiotoxicity.

Authors:  Kim M Truong; Wei Feng; Isaac N Pessah
Journal:  Toxicol Sci       Date:  2020-11-01       Impact factor: 4.849

10.  The Gene Polymorphism of Angiotensin-Converting Enzyme Intron Deletion and Angiotensin-Converting Enzyme G2350A in Patients With Left Ventricular Hypertrophy: A Meta-analysis.

Authors:  Jonny Karunia Fajar; Budi Susetio Pikir; Erdo Puncak Sidarta; Putu Nina Berlinda Saka; Rizal Rahmanda Akbar; Teuku Heriansyah
Journal:  Indian Heart J       Date:  2019-07-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.